-
Reserpine (N1867): Practical Lab Workflow
2026-09-15
Reserpine (SKU N1867) provides a defined research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows when direct matched paper evidence is unavailable. This guide addresses identity confirmation, DMSO-based preparation, storage, and QC while emphasizing that the material is for research use only, not for diagnostic, therapeutic, or medical applications.
-
Octenidine: Translational Antisepsis by Design
2026-09-15
A mechanistic and strategic guide to using Octenidine dihydrochloride as a membrane-targeting antiseptic research compound, with evidence-based workflow recommendations and perspective from next-generation gemini quaternary ammonium compounds.
-
Clozapine N-oxide: DREADD Chemogenetics
2026-09-14
Clozapine N-oxide (CNO) is a clozapine metabolite used to activate engineered muscarinic DREADDs for reversible neuronal activity modulation. Its value as a neuroscience research tool depends on receptor expression, appropriate controls, solution handling, and recognition that in vivo conversion to clozapine can complicate selectivity.
-
Antibacterial Use and Resistance in Psychiatric Hospitals
2026-09-14
This retrospective study examines antibacterial prescribing, microbiological testing, and resistance patterns in a psychiatric hospital during the 2022 epidemic, with comparisons against Jiangsu Province and national monitoring data. Its main contribution is to show that relatively restrained antibiotic consumption can coexist with clinically important resistance, supporting continuous surveillance and setting-specific antimicrobial stewardship.
-
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301)
2026-09-13
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnetic capture of biotinylated proteins, peptides, antibodies, sugars, oligonucleotides, and nucleic acids from purified or complex samples. They are suitable for immunoprecipitation, purification, interaction assays, and screening workflows, but the supplied BSA and sodium azide require compatibility checks before live-cell, mass-spectrometry, or sensitive enzymatic applications.
-
Selonsertib (GS-4997) for ASK1 Research
2026-09-12
Selonsertib (GS-4997) is a selective ASK1 ATP-competitive inhibitor for connecting oxidative stress to p38/JNK signaling, inflammation, and fibrosis. This workflow translates lupus nephritis findings into practical cell and animal assay strategies while separating literature-backed conditions from optimization recommendations.
-
Elobixibat hydrate: IBAT Research Workflows
2026-09-12
Elobixibat hydrate enables selective control of ileal bile acid transport for constipation, colonoscopy-preparation, and gut–metabolic research. This workflow-focused guide covers vehicle selection, epithelial assays, bile-acid readouts, translational endpoints, and troubleshooting.
-
Hesperadin: Aurora B Kinase Inhibitor Workflows
2026-09-11
Hesperadin is an ATP-competitive Aurora B kinase inhibitor for separating mitotic phosphorylation defects from broader cytotoxicity. This workflow-focused guide shows how to connect histone H3 Ser-10 loss, chromosome missegregation, polyploidization, and spindle checkpoint phenotypes with practical controls and troubleshooting.
-
ATM Inhibition and Fenofibrate in HGSOC
2026-09-11
A Heliyon study identified a metabolic vulnerability associated with ATM signaling in high-grade serous ovarian cancer (HGSOC). By integrating tumor datasets, Dependency Map drug-response data, and cell-based experiments, the authors showed that pharmacologic ATM inhibition can synergize with fenofibrate and promote senescence, suggesting a combination strategy beyond conventional DNA-damaging treatments.
-
Resveratrol: From SIRT1 Signal to Assay Design
2026-09-10
Resveratrol is widely used as a SIRT1 activator, but its value in neurodegeneration research depends on connecting pathway activation with mitochondrial and apoptotic readouts. This article translates the 2024 N2a prion-toxicity study into a mechanism-led framework for designing and interpreting neuroprotection assays.
-
Deferoxamine (DeferoxamineB) Assay Guide
2026-09-10
Learn how Deferoxamine (DeferoxamineB), SKU BA2746, can improve interpretation of iron-dependent viability, proliferation, and regulated cell-death assays. This scenario-based guide covers mechanistic controls, stock preparation, metabolic confounding, and practical product-selection criteria.
-
Partial BACE Inhibition and Synaptic Transmission
2026-09-09
Satir et al. showed that moderate β-secretase (BACE) inhibition can reduce amyloid β secretion by up to approximately 50% without measurably impairing synaptic transmission in primary cortical neuronal cultures. The study defines a potentially useful exposure window for prevention-oriented Alzheimer’s disease research while showing that stronger BACE inhibition can compromise neuronal function.
-
Network Medicine and Apigenin in Alzheimer’s Disease
2026-09-09
A 2025 study used network medicine to screen flavonoids by their proximity to Alzheimer’s disease targets, prioritizing Apigenin as the strongest candidate among four experimentally tested compounds. Computational predictions and cell-based validation linked Apigenin with protection against mitochondrial dysfunction, apoptosis, and microglia-driven neuroinflammation, while also identifying AKT1 and NFKBIA as important candidate targets.
-
Drug Response Measurement in Cancer: Schwartz's Study
2026-09-08
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing why growth inhibition and cell killing should not be treated as interchangeable drug-response endpoints. The framework offers practical guidance for time-aware in vitro cancer research, including studies of mitotic agents and cell cycle arrest in mitosis.
-
Protease and Phosphatase Inhibitor Cocktail Workflow
2026-09-08
Protect total protein and phosphorylation-dependent readouts with an EDTA-free, 100X workflow designed for rapid extraction from cells, tissues, and microbial samples. The protocol also shows how preserved lysates can strengthen chamber-specific cardiomyocyte studies without confusing sample protection with cell differentiation.